Breast Lift in US
Breast Lift in US section, includes general infrmation about Breast Lift Procedure, Breast Lift US Local News, Breast Lift US Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift US (current)
US Breast Reduction
US Breast Implants
US Implant Removal
US Armpit Incision
More US info...
United States Other destinations Statue of LibertyThese are some of the largest and most famous destinations outside of major cities.
United States Cities Cities and Other destinations in the United StatesThe United States has over 10,000 cities, towns, and villages. The following is a list of nine of the most notable. Other cities can be found in their corresponding regions.
Plastic Surgery News...
- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer's chemotherapy agent, Camptosar(R) (Irinotecan Hydrochloride) Injection, 20 mg/mL.
- The Committee for Medicinal Products for Human Use (CHMP) of the EMEA has issued a “Question and answer” document discussing the withdrawal of the application for a change to the marketing authorisation for zoledronic acid (Zometa) to include the prevention of fractures and bone loss in postmenopausal women with early-stage breast cancer who were being treated with aromatase inhibitors.
The CHMP comments that the studies supporting the application for the change in indication did not look directly at bone fractures. Additionally, the CHMP was concerned that there was insufficient information to show that the dose of zoledronic acid used in the studies was the most appropriate for these patients.